articleThe Lancet OncologyMay 7, 2020Closed access

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

CACatherine A. ShuJFJustin F. GainorMMMark M. AwadCCCodruța ChiuzanCGClaud Grigg

Columbia University Irving Medical Center · Massachusetts General Hospital · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

633
total citations
FWCI
37.15
Percentile
100%
References
34
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Atezolizumab
  • Medicine
  • Carboplatin
  • Clinical endpoint
  • Lung cancer
  • Perioperative
  • Internal medicine
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding